Earnings Feed
Start Free
Home/Filings/4/0000707549-25-000020
4//SEC Filing

Varadarajan Seshasayee 4

Accession 0000707549-25-000020

CIK 0000707549other
View on SEC.govCompany Profile

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:10 PM ET

Size

21.3 KB

Accession

0000707549-25-000020

Insider Transaction Report

Form 4
Period: 2025-02-04
LAM RESEARCH CORPLRCX
Varadarajan Seshasayee
Senior Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-04+14,542→ 179,084 total
  • Exercise/Conversion

    Market-based Performance Restricted Stock Unit

    2025-02-04−25,540→ 0 total
    Exercise: $0.00→ Common Stock (25,540 underlying)
Holdings

  • Employee Stock Option (Right to Buy)

    Exercise: $30.03Exp: 2027-03-02→ Common Stock (27,480 underlying)
    27,480

  • Employee Stock Option (Right to Buy)

    Exercise: $17.68Exp: 2026-03-01→ Common Stock (74,320 underlying)
    74,320

  • Market-based Performance Restricted Stock Unit

    Exercise: $0.00→ Common Stock (35,950 underlying)
    35,950

  • Employee Stock Option (Right to Buy)

    Exercise: $54.06Exp: 2029-03-01→ Common Stock (20,880 underlying)
    20,880

  • Employee Stock Option (Right to Buy)

    Exercise: $49.09Exp: 2030-03-01→ Common Stock (29,400 underlying)
    29,400

  • Common Stock

    (indirect: By 401(k))
    2,366.994

  • Market-based Performance Restricted Stock Unit

    Exercise: $0.00→ Common Stock (29,190 underlying)
    29,190

  • Employee Stock Option (Right to Buy)

    Exercise: $98.15Exp: 2031-03-01→ Common Stock (23,880 underlying)
    23,880

  • Employee Stock Option (Right to Buy)

    Exercise: $59.88Exp: 2028-03-01→ Common Stock (12,270 underlying)
    12,270

  • Employee Stock Option (Right to Buy)

    Exercise: $19.01Exp: 2025-03-01→ Common Stock (35,760 underlying)
    35,760
Footnotes (12)
  • [F1]On 03/01/2022, the Reporting Person received a target grant of 25,540 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2025. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2022 through 01/31/2025.
  • [F10]The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025
  • [F11]The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026
  • [F12]The stock options will become exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021.
  • [F2]The amount reported includes shares subject to unvested restricted stock units.
  • [F3]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025.
  • [F4]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2027. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2024 through 01/31/2027.
  • [F5]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026.
  • [F6]The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024
  • [F7]The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
  • [F8]The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.
  • [F9]The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022.

Documents

1 file

Issuer

LAM RESEARCH CORP

CIK 0000707549

→
Entity typeother

Related Parties

1
  • filerCIK 0001707827

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:10 PM ET
Size
21.3 KB
View on SEC.gov